ChemicalBook > Product Catalog >Pharmaceutical intermediates >Bulk Drug Intermediates >Prednisone Impurity 13

Prednisone Impurity 13

Prednisone Impurity 13 Suppliers list
Company Name: Quality Control Solutions Ltd.  
Tel: 0755-66853366 13670046396
Email: orders@qcsrm.com
Company Name: Hubei Yangxin Medical Technology Co., Ltd.  
Tel: 15374522761
Email: 3003392093@yongstandards.com
Company Name: Shenzhen Polymeri Biochemical Technology Co., Ltd.  
Tel: +86-400-002-6226
Email: sales@rrkchem.com
Company Name: Jinan Ruisi Pharmaceutical Technology Co., LTD  
Tel: 0531-0531-69900633 19963472814
Email: changyuan20@163.com
Company Name: Jinan blalong chemical co. LTD  
Tel: 2710913286@qq.com
Email: 1513643261@qq.com
Prednisone Impurity 13 Basic information
Product Name:Prednisone Impurity 13
Synonyms:Prednisone Impurity 13;9α-bromo-11β,16α,17α,21-tetrahydroxypregnane-1,4-diene-3,20-dione-21-acetate;BNKY015-BD02;(11β,16α)-21-(Acetyloxy)-9-bromo-11,16,17-trihydroxy-pregna-1,4-diene-3,20-dione;Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-bromo-11,16,17-trihydroxy-, (11β,16α)-;Prednisone Impurity 5;Budesonide Impurity 53;((8S,9R,10S,11S,13S,14S,16R,17S)-9-bromo-11,16,17-trihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
CAS:91160-89-3
MF:C23H29BrO7
MW:497.38
EINECS:
Product Categories:
Mol File:91160-89-3.mol
Prednisone Impurity 13 Structure
Prednisone Impurity 13 Chemical Properties
Boiling point 636.3±55.0 °C(Predicted)
density 1.53±0.1 g/cm3(Predicted)
pka11.57±0.70(Predicted)
InChIKeyLTRVYEKAPGRFOX-WFWLZCIZNA-N
SMILESC[C@]12C[C@H](O)[C@@]3([C@]4(C=CC(=O)C=C4CC[C@@]3([H])[C@]1([H])C[C@@H](O)[C@]2(O)C(=O)COC(=O)C)C)Br |&1:1,3,5,6,15,17,20,22,r|
Safety Information
MSDS Information
Prednisone Impurity 13 Usage And Synthesis
Uses(11β,16α)-21-(Acetyloxy)-9-bromo-11,16,17-trihydroxy-pregna-1,4-diene-3,20-dione is used as a reactant in the synthesis of triamcinolone acetonide, a synthetic corticosteroid used to treat skin conditions.
Synthesis 50.5 g of 2-((8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate was dissolved in 1500 ml of acetone, 70 ml of 5% perchloric acid was added, the temperature was lowered to 0°C with stirring, and 45 g of N-bromosuccinimide was added and stirred After the reaction was completed, 50 ml of 20% sodium sulfite aqueous solution was added, the acetone was concentrated, the water was separated, filtered, and dried to obtain 62 g of Prednisone Impurity 13 (9α-bromo-11β,16α,17α,21-tetrahydroxypregnane-1,4-diene-3,20-dione-21-acetate).
Prednisone Impurity 13
Tag:Prednisone Impurity 13(91160-89-3) Related Product Information
9-Bromo-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 21-acetate Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-bromo-11,17-dihydroxy-, (11β)- Prednisolone, 9-bromo-6.alpha.-methyl-, 21-acetate Pregna-1,4-diene-3,20-dione, 9-bromo-11,21-dihydroxy-16-methyl-17-(1-oxopropoxy)-, (11β,16β)- (9CI) (11β,16β)-9-BroMo-11-hydroxy-16-Methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-bromo-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11β,16β)- (9CI)